You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PODOFILOX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Podofilox patents expire, and when can generic versions of Podofilox launch?

Podofilox is a drug marketed by Padagis Us and Bausch And Lomb Inc and is included in three NDAs.

The generic ingredient in PODOFILOX is podofilox. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the podofilox profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Podofilox

A generic version of PODOFILOX was approved as podofilox by PADAGIS US on January 29th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PODOFILOX?
  • What are the global sales for PODOFILOX?
  • What is Average Wholesale Price for PODOFILOX?
Summary for PODOFILOX
Drug patent expirations by year for PODOFILOX
Drug Prices for PODOFILOX

See drug prices for PODOFILOX

Recent Clinical Trials for PODOFILOX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hyloris Developments SAPhase 3
bioRASI, LLCPhase 3
Dermax SAPhase 3

See all PODOFILOX clinical trials

Pharmacology for PODOFILOX
Physiological EffectDecreased Mitosis

US Patents and Regulatory Information for PODOFILOX

PODOFILOX is protected by zero US patents and one FDA Regulatory Exclusivity.

FDA Regulatory Exclusivity protecting PODOFILOX

COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Padagis Us PODOFILOX podofilox GEL;TOPICAL 211871-001 Nov 22, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch And Lomb Inc PODOFILOX podofilox SOLUTION;TOPICAL 090184-001 Jul 21, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Padagis Us PODOFILOX podofilox SOLUTION;TOPICAL 075600-001 Jan 29, 2002 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.